Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
254.81
+6.46 (2.60%)
At close: Nov 9, 2026, 4:00 PM EST
254.88
+0.07 (0.03%)
After-hours: Nov 9, 2026, 6:15 PM EST

Biogen Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,3043,0092,3751,0503,4192,261
Short-Term Investments
-807.2--1,4741,541
Cash & Short-Term Investments
1,3043,8162,3751,0504,8933,803
Cash Growth
-67.08%60.66%126.21%-78.54%28.67%45.68%
Accounts Receivable
2,3831,8671,8692,1002,1361,962
Other Receivables
---430798.8-
Receivables
2,3831,8671,8692,5302,9351,962
Inventory
2,2242,1682,4612,5271,3441,352
Prepaid Expenses
943.7693.6307.2---
Other Current Assets
729.8429.7445.3752618.8740.8
Total Current Assets
7,5848,9747,4576,8599,7917,857
Property, Plant & Equipment
3,1443,3213,5383,7303,7033,792
Long-Term Investments
458.1954.5423.8625.81,7762,826
Goodwill
6,9936,4916,4796,2195,7495,761
Other Intangible Assets
13,3809,1799,6918,3631,8502,221
Long-Term Deferred Tax Assets
293.7292.5324.2928.61,2261,415
Other Long-Term Assets
201.7198136.7119.2459.35.5
Total Assets
32,05429,44028,04926,84524,55423,877

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
430.3432424.2403.3491.5589.2
Accrued Expenses
1,8191,6791,5041,4531,4971,382
Current Portion of Long-Term Debt
400-1,749150-999.1
Current Portion of Leases
-80.486.490.397.289.1
Current Income Taxes Payable
54.5114.8548.3257.4259.9174.7
Other Current Liabilities
1,1951,0441,2181,080927.61,064
Total Current Liabilities
3,8983,3495,5293,4343,2734,298
Long-Term Debt
7,2926,2874,5476,7886,2816,274
Long-Term Leases
109.3290.4334.5400333330.4
Long-Term Deferred Tax Liabilities
1,164507.6190.5641.8334.7694.5
Other Long-Term Liabilities
668.4748.5732.3781.1944.21,321
Total Liabilities
13,13211,18311,33312,04511,16612,918

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.10.10.10.10.1
Additional Paid-In Capital
1,070863.1569.4302.573.368.2
Retained Earnings
20,94920,55319,26017,62816,46713,912
Treasury Stock
-2,977-2,977-2,977-2,977-2,977-2,977
Comprehensive Income & Other
-120.3-182-136.2-153.7-164.9-106.7
Total Common Equity
18,92218,25716,71614,79913,39810,896
Minority Interest
-----9.563.5
Shareholders' Equity
18,92218,25716,71614,79913,38810,960
Total Liabilities & Equity
32,05429,44028,04926,84524,55423,877

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
7,8016,6586,7177,4296,7117,693
Net Cash (Debt)
-6,497-2,410-4,342-6,379-1,113-2,998
Net Cash Growth
------
Net Cash Per Share
-43.70-16.38-29.76-43.81-7.62-20.04
Filing Date Shares Outstanding
147.82146.76146.37145.36144.49146.96
Total Common Shares Outstanding
147.8146.8145.8144.9144.1147
Working Capital
3,6865,6251,9283,4256,5183,558
Book Value Per Share
128.03124.37114.65102.1492.9874.12
Tangible Book Value
-1,4502,587545.9217.25,7992,914
Tangible Book Value Per Share
-9.8117.623.741.5040.2419.82
Land
-216.7202.4202.4202.4207.5
Buildings
-2,1401,9641,6011,5931,700
Machinery
-2,2302,1691,7651,6731,653
Construction In Progress
-163.1308.4975.4888.8770.3
Leasehold Improvements
-143.5137.8135.7107.7121
SEC Filings: 10-K · 10-Q